1
Peter Traxler, Pascal Furet, Guido Bold, Jorg Frei, Marc Lang: Pyrazole derivatives and processes for the preparation thereof. Novartis, Joseph J Borovian, November 9, 1999: US05981533 (53 worldwide citation)

4-Amino-1H-pyrazolo[3,4-d]pyrimidine derivatives of formula I ##STR1## wherein the symbols are as defined in claim 1, and intermediates for their manufacture are described.


2

3

4
Andreas Huth, Dieter Seidelmann, Karl Heinz Thierauch, Guido Bold, Paul William Manley, Pascal Furet, Jeanette Marjorie Wood, Jürgen Mestan, Jose Brüggen, Stefano Ferrari, Martin Krüger, Eckhard Ottow, Andreas Menrad, Michael Schirner: Anthranilic acid amides and the use thereof as medicaments. Schering, Novartis, Millen White Zelano & Branigan P C, October 17, 2006: US07122547 (36 worldwide citation)

The invention relates to anthranilic acid amides and the use thereof as medicaments for the treatment of diseases that are triggered by persistent angiogenesis, in addition to intermediate products in the production of anthranilic acid amides.


5
Guido Bold, Hans Georg Capraro, Alexander Fassler, Marc Lang, Shripad Subray Bhagwat, Satish Chandra Khanna, Janis Karlis Lazdins, Jurgen Mestan: Antiviral ethers of aspartate protease substrate isosteres. Novartis, Gregory D Ferraro, September 15, 1998: US05807891 (31 worldwide citation)

Antiretroviral compounds (which are effective, for example, against HIV) of the formula I ##STR1## in which R.sub.1 is an acyl radical lower-alkoxy-lower-alkanoyl whose lower alkoxy radical is unsubstituted or is substituted by halogen, phenyl, lower alkoxy or a heterocyclic radical selected from pi ...


6
Karl Heinz Altmann, Guido Bold, Giorgio Caravatti, Andreas Flörsheimer: Epothilone derivatives and their use as antitumor agents. Novatis, George R Dohmann, May 14, 2002: US06387927 (29 worldwide citation)

The invention relates to anti-tumour-effective compounds of formula (I), wherein the radicals have the meanings given in the description.


7
Guido Bold, Shripad S Bhagwat, Alexander Fassler, Marc Lang: Cyclic hydrazine compounds. Ciba Geigy Corporation, Marla J Mathias, September 23, 1997: US05670497 (27 worldwide citation)

This invention relates to substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors to pharmaceutical compositions comprising such compounds, and to methods of using these compounds for treating vital infection.


8

9

10